Información:
Error:
ID
34169
Descripción
Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01395056
Link
https://clinicaltrials.gov/show/NCT01395056
Palabras clave
Versiones (1)
- 15/1/19 15/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
15 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Neoplasms NCT01395056
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01395056
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
failure to anthracycline and/or taxol chemotherapy;
boolean
ID.2
Item
metastatic tumor is histologically confirmed by immunohistochemical staining to be er-negative and pr-negative. fish testing for her-2-negative;
boolean
ID.3
Item
metastatic tumor can not be removed through surgery procedure;
boolean
ID.4
Item
an eastern cooperative oncology group (ecog) performance status of 0-2;
boolean
ID.5
Item
normal cardiac, hepatic, renal and bone marrow functions;
boolean
ID.6
Item
life expectancy ≥3 months.
boolean
ID.7
Item
central nervous system metastases;
boolean
ID.8
Item
serious or uncontrolled concurrent medical illness;
boolean
ID.9
Item
history of other malignancies;
boolean
ID.10
Item
having been enrolled in some other clinal trials within a month;
boolean